These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 646523)

  • 1. CNS effects of anticholinesterases in the presence of inhibited cholinesterases.
    Van Meter WG; Karczmar AG; Fiscus RR
    Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):249-60. PubMed ID: 646523
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship between cholinesterase activity and brain permeability to barbitone.
    Rosić N; Milosević MP
    Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):302-7. PubMed ID: 6047617
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of atropine and cholinesterase inhibitors on brain potentials caused by dental pulp stimulation].
    Schmidt J; Wolf H
    Acta Biol Med Ger; 1972; 29(4):723-8. PubMed ID: 4653305
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between acetylcholine and cholinesterase activity in the brain following organophosphorus cholinesterase inhibitors.
    Awad O
    Arzneimittelforschung; 1972 Nov; 22(11):1926-7. PubMed ID: 4679066
    [No Abstract]   [Full Text] [Related]  

  • 5. Lens organ culture. II. Pharmacologic evaluation.
    Haddad HM; Furman M; Shore B
    Am J Ophthalmol; 1967 Jun; 63(6):1737-43. PubMed ID: 6027350
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of physostigmine on cholinesterase activity in different parts of rat brain.
    Osman MY; Abdel Tawab SM; Sharaf IA
    Arzneimittelforschung; 1995 Jun; 45(6):663-5. PubMed ID: 7646566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cholinesterase inhibition on the visual evoked potentials in the rabbit and their modification with various drugs.
    Rump S; Rabsztyn T; Kopeć J
    Act Nerv Super (Praha); 1974 Aug; 16(3):224-5. PubMed ID: 4418665
    [No Abstract]   [Full Text] [Related]  

  • 8. Physical exercise affects cholinesterases and organophosphate response.
    Ryhänen R; Kajovaara M; Harri M; Kaliste-Korhonen E; Hänninen O
    Gen Pharmacol; 1988; 19(6):815-8. PubMed ID: 3229622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of diisopropyl phosphorofluoridate on acetylcholine, cholinesterase and catecholamines of several parts of rabbit brain.
    Glisson SN; Karczmar AG; Barnes L
    Neuropharmacology; 1974 Jul; 13(7):623-31. PubMed ID: 4437735
    [No Abstract]   [Full Text] [Related]  

  • 10. The potentiation by anticholinesterase drugs of the responses of the guinea-pig isolated vas deferens to alternate preganglionic and postganglionic stimulation.
    Birmingham AT
    Br J Pharmacol Chemother; 1966 May; 27(1):145-56. PubMed ID: 6006720
    [No Abstract]   [Full Text] [Related]  

  • 11. Long latent periods and further analysis of slow synaptic responses in sympathetic ganglia.
    Libet B
    J Neurophysiol; 1967 May; 30(3):494-514. PubMed ID: 6037590
    [No Abstract]   [Full Text] [Related]  

  • 12. Age and the sensitivity of chicks to the delayed neurotoxic effects on some organophosphorus compounds.
    Johnson MK; Barnes JM
    Biochem Pharmacol; 1970 Dec; 19(12):3045-7. PubMed ID: 5513043
    [No Abstract]   [Full Text] [Related]  

  • 13. Histochemical studies of cholinesterases in Ciona intestinalis.
    Scudder CL; Karczmar AG
    Comp Biochem Physiol; 1966 Feb; 17(2):553-8. PubMed ID: 4287477
    [No Abstract]   [Full Text] [Related]  

  • 14. Depression of the photic after discharge of flash evoked potentials by physostigmine, carbaryl and propoxur, and the relationship to inhibition of brain cholinesterase.
    Mwanza JC; Finley D; Spivey CL; Graff JE; Herr DW
    Neurotoxicology; 2008 Jan; 29(1):87-100. PubMed ID: 17950890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between oxotremorine and inhibitors of cholinesterase enzymes.
    Cox B; Tha SJ
    J Pharm Pharmacol; 1973 Jul; 25(7):544-9. PubMed ID: 4147051
    [No Abstract]   [Full Text] [Related]  

  • 16. Ocular tissue cholinesterases kinetics of enzyme activity and inhibition.
    Ellis PP
    Trans Am Ophthalmol Soc; 1971; 69():358-82. PubMed ID: 5005214
    [No Abstract]   [Full Text] [Related]  

  • 17. Protection from quinidine or physostigmine against in vitro inhibition by sarin of acetylcholinesterase activity.
    Singh AK; Zeleznikar RJ; Drewes LR
    Life Sci; 1986 Jan; 38(2):165-72. PubMed ID: 3945161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of organophosphates on bioelectrical activity of the brain.
    Rump S
    Pol J Pharmacol Pharm; 1990; 42(6):563-72. PubMed ID: 2103006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of DFP and obidoxime on brain acetylcholine levels on brain and peripheral cholinesterases.
    Mayer O; Michalek H
    Biochem Pharmacol; 1971 Nov; 20(11):3029-37. PubMed ID: 4943596
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed neurologic and behavioral effects of subtoxic doses of cholinesterase inhibitors.
    Scremin OU; Shih TM; Huynh L; Roch M; Booth R; Jenden DJ
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1111-9. PubMed ID: 12604688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.